YOLFTbeta
32

JLK Inc

322510 · KQ · Industrials / Conglomerates

3,895.00KRW-80.00 (-2.01%)

Price History

Full chart

Market Stats

Previous Close3,975.00
Open4,000.00
Day Range3,895.00 – 4,170.00
52-Week Range3,765.00 – 9,210.00
Volume95.16K
Market Cap131.36B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.26
50-Day Avg5,010.50
200-Day Avg5,938.70

About

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.

Company Details

  • SectorIndustrials
  • IndustryConglomerates
  • CEOMr. Dongmin Kim
  • Employees74
  • Headquarters#204, 10, Yangcheongsongdae-gil, Cheongju-si, South Korea, Korea
  • Websitehttps://www.jlkgroup.com

Leadership

  • Mr. Dongmin KimChief Executive Officer · b. 1977
  • ShinWook KangSenior Vice President
  • MyoungJae LeeSenior Vice President
  • WiSeon YooMD & Internal Director · b. 1979

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue84.09M362.91M229.53M4.49B3.79B3.42B2.49B1.43B3.34B
Growth (%)-+331.57%-36.75%+1856.13%-15.68%-9.79%-27.12%-42.65%+133.94%
Cost of Revenue27.06M66.40M56.49M6.58B5.39B5.61B5.56B7.87B-
Gross Profit57.03M296.51M173.05M-2.09B-1.61B-2.19B-3.07B-6.45B3.34B
Gross Margin67.82%81.70%75.39%-46.53%-42.49%-64.20%-123.47%-451.51%100.00%
Operating Expense2.59B4.91B10.97B5.44B5.82B6.57B4.07B6.29B16.54B
Operating Income-2.53B-4.62B-10.79B-7.53B-7.42B-8.76B-7.15B-12.73B-13.20B
Operating Margin-3007.20%-1272.23%-4702.46%-167.80%-196.10%-256.43%-287.17%-891.88%-395.33%
EBITDA------7.77B-5.42B-11.61B-11.36B
EBITDA Margin------227.61%-217.75%-813.02%-340.24%
Net Income-8.41B-6.28B-10.64B-7.64B-7.57B-9.01B-7.32B-13.45B-13.61B
Net Income Margin-10002.02%-1729.70%-4637.28%-170.09%-200.05%-263.86%-294.23%-942.46%-407.43%
R&D--2.52B2.47B2.54B2.94B1.20B2.74B3.37B
R&D as % of Total Revenue--1098.91%54.93%67.20%86.03%48.35%191.82%101.01%
Interest Expense0043.34M300.09M399.24M446.20M968.93M1.11B2.01B
Interest Expense % of Total Revenue0.00%0.00%18.88%6.68%10.54%13.06%38.93%77.85%60.15%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.25B9.42B38.70B46.55B40.45B36.33B33.15B74.59B74.43B
Total Liabilities13.90B3.33B2.40B15.88B16.36B19.71B21.43B25.28B33.07B
Total Equity-8.64B6.10B36.30B30.67B24.08B16.62B11.73B49.31B41.36B
Cash2.38B3.32B16.02B12.81B10.86B8.16B6.11B12.72B3.86B
Total Debt2.55B1.75B63.58M11.67B-----
Net Debt----603.69M8.18B11.89B9.28B26.18B

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.21B-3.82B-6.42B-4.12B-6.10B-7.90B-6.38B-10.94B-12.34B
Investing Cash Flow6.13B-3.41B-16.35B-10.81B3.80B-114.10M-220.56M-35.23B-
Financing Cash Flow-4.45B8.17B35.49B11.73B333.86M5.33B4.55B52.74B-
Capital Expenditure1.20B724.99M288.71M17.45B1.45B471.46M364.35M60.03M334.65M
Free Cash Flow----15.96B-7.55B-8.37B-6.74B-11.00B-12.68B
FCF to OCF---387.83%123.79%105.97%105.71%100.55%102.71%

Earnings

Report DateDec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------
EPS Actual-157.00-120.52-138.88-140.312.73-138.91-121.19-121.70-10.40-171.74-137.75-93.78-61.29-46.86-112.75-117.50-80.89-187.75-159.16-183.29-110.89-127.59-112.09-85.99-214.49-149.69-146.42
Surprise---------------------------
Timing---------------------------

Key Statistics & Ratios

Market Cap131.36B
Enterprise Value112.21B
Trailing P/E0.00
Forward P/E0.00
Price / Sales48.23
Price / Book3.53
Revenue (TTM)2.72B
Gross Profit (TTM)2.66B
EBITDA-12.90B
Profit Margin0.00%
Operating Margin-643.51%
Return on Equity-38.50%
Return on Assets-12.26%
Shares Outstanding25.56M
Shares Float20.17M
Beta1.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 17, 20246:5
  • Aug 14, 20242257:2078